Trxade Health Inc MEDS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MEDS is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $7.06
- Day Range
- $6.78–7.68
- 52-Week Range
- $3.69–44.56
- Bid/Ask
- $6.00 / $9.14
- Market Cap
- $8.53 Mil
- Volume/Avg
- 123 / 486,414
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.57
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Trxade Health Inc is a health service IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey, and patient engagement in the U.S. Its product and services include Integra Pharma Solutions, LLC, Community Specialty Pharmacy, LLC, Delivmeds.com, Bonum Health Hub and Application, and others. its business is classified into reportable segments which are Trxade, Inc, Community Specialty Pharmacy, LLC, Integra Pharma, LLC, and Other, and the majority of the revenue comes from Trxade, Inc.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Stock Style Box
- Small Core
- Total Number of Employees
- 34
- Website
- https://www.rx.trxade.com
Valuation
Metric
|
MEDS
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.50 |
Price/Sales | 1.57 |
Price/Cash Flow | — |
Price/Earnings
MEDS
Financial Strength
Metric
|
MEDS
|
---|---|
Quick Ratio | 0.25 |
Current Ratio | 0.61 |
Interest Coverage | −4.72 |
Quick Ratio
MEDS
Profitability
Metric
|
MEDS
|
---|---|
Return on Assets (Normalized) | −34.98% |
Return on Equity (Normalized) | −101.17% |
Return on Invested Capital (Normalized) | −40.54% |
Return on Assets
MEDS
Pharmaceutical Retailers Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
WBA
| Walgreens Boots Alliance Inc | Svxhhvcp | Rqtxm | $15.2 Bil | |
RADLY
| Raia Drogasil SA ADR | — | Jffxnfs | $8.1 Bil | |
MSMKF
| MatsukiyoCocokara & Co | — | Cknsnp | $6.2 Bil | |
ALBHF
| Alibaba Health Information Technology Ltd | — | Qmmzgs | $5.4 Bil | |
ALBBY
| Alibaba Health Information Technology Ltd ADR | — | Mvtnncv | $5.4 Bil | |
CLCGY
| Clicks Group Ltd ADR | — | Jpkxwb | $3.5 Bil | |
TSUSF
| Tsuruha Holdings Inc | — | Mvhcts | $3.2 Bil | |
SGIPF
| Sugi Holdings Co Ltd | — | Wmh | $2.8 Bil | |
SAEYY
| Redcare Pharmacy NV ADR | — | Qgw | $2.6 Bil | |
SHPPF
| Redcare Pharmacy NV | — | Rzqs | $2.6 Bil |